Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: Results from the hirulog and early reperfusion or occlusion-2 trial

Heart

Volumn 95, Issue 4, 2009, Pages 276-282

  Wong, C K ^a   Gao, W ^b   Stewart, R A H ^c   French, J K ^d   Aylward, P E G ^e   White, H D ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d LIVERPOOL HOSPITAL   (Australia)

^e FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY HEMODYNAMICS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART CONDUCTION; HEART INFARCTION; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; REPERFUSION; SMOKING; ST SEGMENT ELEVATION; STROKE; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TRANSIENT ISCHEMIC ATTACK;

AGED; BUNDLE-BRANCH BLOCK; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 62149139342     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.146365     Document Type: Article

References (14)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311- 22.
2. Norris RM, Croxson MS. Bundle branch block in acute myocardial infarction. Am Heart J 1970;79:728-33.
3. Wong CK, Stewart RAH, Gao W, et al. Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Eur Heart J 2006;27:21-8.
4. Wong CK, Gao W, Stewart RA, et al. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy. Circulation 2006;114:783-9.
5. Schroder R, Wegscheider K, Schroder K, et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens: a substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995;26:1657- 64.
6. Schroder K, Wegscheider K, Zeymer U, et al. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of mediumterm mortality in acute myocardial infarction. Lancet 2001;358:1479-86.
7. Cura FA, Roffi M, Pasca N, et al. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Am J Cardiol 2004;94:859-63.
8. Anderson RD, White HD, Ohman EM, et al. Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-HI trial. Am Heart J 2002;144:81-8.
9. de Lemos JA, Antman EM, Giugliano RP, et al. Comparison of a 60-versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2000:86:1235-7.
10. Wong CK, Gao W, Raffel 0C, et al. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet 2006;367:2061-7.
11. The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001;358:1855-63.
12. Wong CK, French JK, Aylward PE, et al. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol 2005;46:29-38.
13. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
14. Hathaway WR, Peterson ED, Wagner GS, et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA 1998;279:387-91.